Angivent MR 35 mg is a modified-release tablet containing Trimetazidine Dihydrochloride, a metabolic anti-ischemic agent. It is primarily used as an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies .